Loading clinical trials...
Loading clinical trials...
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute GVHD
Conditions
Interventions
Prochymal®
Placebo
+1 more
Locations
53
United States
University of Alabama Birmingham (UAB) Hospital
Birmingham, Alabama, United States
UCLA Medical Center
Los Angeles, California, United States
University of California Medical Center
San Francisco, California, United States
Rocky Mountain Cancer Center
Denver, Colorado, United States
University of Florida
Gainesville, Florida, United States
Emory University
Atlanta, Georgia, United States
Start Date
January 31, 2008
Primary Completion Date
July 14, 2009
Completion Date
May 20, 2010
Last Updated
January 19, 2022
NCT06008808
NCT06705062
NCT01804686
NCT07356245
NCT04660487
NCT04745221
Lead Sponsor
Mesoblast, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions